Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception
This double-blind study (n=23) using eye-tracking found that high doses of psilocybin mushrooms (0.5-3g dried) caused more localised visual exploration of paintings and less entropic fixation patterns compared to low doses, while increasing subjective emotional intensity without affecting aesthetic ratings of the artworks.
Authors
- Enzo Tagliazucchi
- Claudio Pallavicini
- Federico Cavanna
Published
Abstract
Serotonergic psychedelics are remarkable for their capacity to induce variable yet reproducible modifications to human consciousness. The acute effects of these compounds include perceptual alterations, predominantly in the visual domain, yet these alterations have been mostly documented only by subjective reports. We used eye-tracking to quantify the effects of low vs. high doses of psilocybin mushrooms on eye movements during the exploration of complex visual stimuli under semi-naturalistic conditions, focusing on the case of aesthetic perception. The experimental condition (high vs. low dose) was a priori unknown to participants and experimenters. High doses resulted in a more local visual exploration of paintings, and a less entropic distribution of fixations. While psilocybin altered gaze behavior and increased subjective emotional intensity and feelings of flow, it did not affect the aesthetic ratings of the stimuli, suggesting a dissociation between perceptual and evaluative aspects of aesthetic experience. These findings suggest that psilocybin may influence gaze fixation by altering the perception of low-level visual features, including textures, shapes, and colors. Our work highlights the possibility of investigating psychedelics by addressing their effect on behavior under complex naturalistic conditions, contributing to maintaining subject engagement while also increasing the ecological validity of the findings.
Research Summary of 'Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception'
Introduction
Earlier research documents robust subjective visual alterations produced by serotonergic psychedelics, but objective behavioural metrics of sensory engagement under these drugs remain underexplored. Muller and colleagues note that eye-tracking provides a quantitative window on how attention is allocated across visual scenes, allowing tests of theoretical proposals about psychedelic action such as the Relaxed Brain Under Psychedelics (REBUS) model. REBUS predicts that psychedelics relax high‑level priors and thus should increase entropy in how visual information is sampled, yet empirical tests using naturalistic stimuli are scarce. This study set out to quantify how an acute high dose of psilocybin mushrooms alters the spatiotemporal dynamics of gaze fixations during free viewing of classical paintings, compared with an active low‑dose control. Using a semi‑naturalistic, self‑blinded design intended to balance ecological validity and experimental control, the investigators combined eye tracking with self‑report measures of acute perceptual intensity, aesthetic experience and altered states to test whether high dose psilocybin increases the entropy and spatial spread of fixations as predicted by REBUS.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topic
- Authors
- APA Citation
Muller, S., Cavanna, F., de la Fuente, L., Bruno, N., D’Amelio, T. A., Pallavicini, C., & Tagliazucchi, E. (2025). Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-10206-8
References (20)
Papers cited by this study that are also in Blossom
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Studerus, E., Gamma, A., Kometer, M. et al. · PLOS ONE (2012)
Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)
Aday, J. S., Bloesch, E. K., Wood, J. R. et al. · Reviews In The Neuroscience (2021)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · Neuroscience and Biobehavioral Reviews (2016)
Szigeti, B., Kartner, L., Blemings, A. et al. · eLife (2021)
Balaet, M. · Frontiers in Neuroscience (2022)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Show all 20 referencesShow fewer
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Cavanna, F., Muller, S., de la Fuente, L. A. et al. · Translational Psychiatry (2022)
Haijen, E. C. H. M., Kaelen, M., Roseman, L. et al. · Frontiers in Pharmacology (2018)
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Aday, J. S., Bloesch, E. K., Davis, A. K. et al. · Journal of Humanistic Psychology (2024)
Aday, J. S., Davis, A. K., Mitzkovitz, C. M. et al. · ACS Pharmacology and Translational Science (2021)
Kaelen, M., Barrett, F. S., Roseman, L. et al. · Psychopharmacology (2015)
Maia, L. O., Feilding, A., Ribeiro, S. et al. · Psychopharmacology (2021)
Van Elk, M., Fejer, G., Lempe, P. et al. · Psychopharmacology (2021)
Sanz, C., Pallavicini, C., Carrillo, F. et al. · Consciousness and Cognition (2021)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.